AGE/RAGE in diabetic kidney disease and ageing kidney

XQ Wu, DD Zhang, YN Wang, YQ Tan, XY Yu… - Free Radical Biology …, 2021 - Elsevier
Diabetic kidney disease (DKD) is the primary cause of chronic kidney disease that inevitably
progress to end-stage kidney disease. Intervention strategies such as blood glucose control …

Targeting inflammation in diabetic nephropathy: a tale of hope

JA Moreno, C Gomez-Guerrero, S Mas… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Diabetic nephropathy (DN) is the leading cause of chronic kidney disease
(CKD) and end-stage renal disease (ESRD). Beyond the new anti-diabetic drugs that …

Vitamin B6 and diabetes: relationship and molecular mechanisms

E Mascolo, F Vernì - International journal of molecular sciences, 2020 - mdpi.com
Vitamin B6 is a cofactor for approximately 150 reactions that regulate the metabolism of
glucose, lipids, amino acids, DNA, and neurotransmitters. In addition, it plays the role of …

A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and …

AR Alshanwani, H Hagar, S Shaheen… - European Journal of …, 2022 - Elsevier
Liver fibrosis is a common chronic hepatic disease. This study was done to examine the
effect of pyridoxamine against thioacetamide-induced hepatic fibrosis. Animals were divided …

Untargeted metabolomics reveals the preventive effect of Quercetin on nephrotoxicity induced by four organophosphorus pesticide mixtures

Y Hou, T Ding, Z Guan, J Wang, R Yao, Z Yu… - Food and Chemical …, 2023 - Elsevier
This research aimed to explore the protective effect of quercetin against nephrotoxicity
induced by four organophosphate pesticide mixtures (PM) using untargeted metabolomics …

Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease

ENGS Pereira, RR Silvares, EEI Flores… - …, 2020 - Wiley Online Library
Objective We investigated the protective effects of pyridoxamine against metabolic and
microcirculatory complications in nonalcoholic fatty liver disease. Methods Nonalcoholic fatty …

RAGE pathway activation and function in chronic kidney disease and COVID-19

CS Curran, JB Kopp - Frontiers in Medicine, 2022 - frontiersin.org
The multi-ligand receptor for advanced glycation end-products (RAGE) and its ligands are
contributing factors in autoimmunity, cancers, and infectious disease. RAGE activation is …

High-fat diet-induced kidney alterations in rats with metabolic syndrome: Endothelial dysfunction and decreased antioxidant defense

R Rangel Silvares… - … syndrome and obesity …, 2019 - Taylor & Francis
Introduction This study aimed to investigate changes in renal function and the AGE-RAGE
axis in the kidney of a non-genetic animal model of metabolic syndrome (MetS) induced by …

[HTML][HTML] Quantification of the B6 vitamers in human plasma and urine in a study with pyridoxamine as an oral supplement; pyridoxamine as an alternative for …

MDG Van den Eynde, JLJM Scheijen, CDA Stehouwer… - Clinical Nutrition, 2021 - Elsevier
Background and aims Vitamin B6 is involved in a large spectrum of physiological processes
and comprises of the vitamers pyridoxamine (PM), pyridoxal (PL), pyridoxine (PN), and their …

Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions

G Bennici, H Almahasheer, M Alghrably, D Valensin… - RSC …, 2024 - pubs.rsc.org
Diabetes mellitus, a complex metabolic disorder, presents a growing global health
challenge. In 2021, there were 529 million diabetics worldwide. At the super-regional level …